Please try another search
For the nine months ended 30 September 2019, Avadim Health Inc revenues increased 73% to $34.4M. Net loss applicable to common stockholders increased 22% to $31.8M. Revenues reflect Retail pharmacy/consumer segment increase from $11M to $25.9M. Higher net loss reflects Selling and marketing expenses increase of 46% to $34.3M (expense), Interest expense increase from $1.7M to $4.9M (expense).
Period Ending: | Sep 30, 2019 | Dec 31, 2018 | Sep 30, 2018 |
---|---|---|---|
Total Revenue | 34.42 | 9.2 | 19.85 |
Gross Profit | 20.34 | 5.21 | 10.75 |
Operating Income | -25.81 | -9.41 | -23.22 |
Net Income | -31.78 | -24.64 | -24.88 |
Period Ending: | Sep 30, 2019 | Dec 31, 2018 | Sep 30, 2018 |
---|---|---|---|
Total Assets | 32.77 | ||
Total Liabilities | 84 | ||
Total Equity | -51.22 |
Period Ending: | Sep 30, 2019 | Dec 31, 2018 | Sep 30, 2018 |
---|---|---|---|
Period Length: | 9 Months | 12 Months | 9 Months |
Cash From Operating Activities | -19.97 | -31.16 | -21.86 |
Cash From Investing Activities | -0.92 | -0.35 | -0.53 |
Cash From Financing Activities | 10.64 | 44.02 | 19.93 |
Net Change in Cash | -10.25 | 12.51 | -2.47 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review